Patent applications published 6 October 2010
Selected patent applications from the weekly European Patents Bulletin
- Rasagilene formulations, their preparation and use
Teva Pharmaceutical Industries 2234478*
- Compsn and method
Bangor University 2234479*
- Methods and compsns for diagnosing complications of pregnancy
Rosetta Genomics; MOR Research Applications 2234483*
- Stable laquinimod preparations
Teva Pharmaceutical Industries 2234485*
- Benzimidazoles and analogues as RHO kinase inhibitors
The Scripps Research Institute 2234486*
- Anilides and analogues as RHO kinase inhibitors
The Scripps Research Institute 2234487*
- Azolylmethyloxiranes, use thereof and agents containing the same
BASF 2234488*
- Substituted 4-(3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl)-piperidine-1-carboxylic acid esters as A2AR agonists
PGXHealth 2234490*
- Dosage regimens and pharmaceutical compsns and packages for emergency contraception
Teva Women’s Health 2234491*
- Therapeutic use of carbonyl ester lipase inhibitors
University of Cincinnati 2234493*
- Bacteriophage preparation and use
Innovations-Transfert Uphoff 2234497*
- Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota
NV Nutricia 2234505*
- Preparation comprising a creatine component, method for the production thereof, and the use thereof
AlzChem Trostberg 2234506*
- Organic compounds
Novartis 2234595*
- Carrier
UCL Business 2234596*
- Enhancing photostabilisation of oxymetazoline
Schering-Plough Healthcare Products 2234597*
- Pharmaceutical compsns containing at least one proteinaceous active ingredient protected against digestive enzymes
Bennis, Farid 2234598*
- Implantable devices for promoting re-endo-thelialisation and methods of use thereof
Estracure 2234599*
- Antibody formulation
F Hoffmann-La Roche 2234600*
- Compsns and methods for reducing or preventing water loss from the skin
Schering-Plough Healthcare Products 2234601*
- Active pharmaceutical ingredient on a solid support, amorphous and with an improved solubility
LEK Pharmaceuticals 2234602*
- Room temperature stable, lyophilised natriuretic peptide formulations
EKR Therapeutics 2234603*
- Pharmaceutical compsns
Biovail Laboratories International 2234604*
- Transdermal therapeutic system having urea components
LTS Lohmann Therapie-Systeme 2234605*
- Edible film-strips with modified release active ingredients
McNeil-PPC 2234606*
- A slow-release formulation based on an association of glycogen and alginate
Aziende Chimiche Riunite Angelini Francesco 2234607*
- Metalloenzyme inhibitors using metal bonding moieties in combination with targeting moieties
Viamet Pharmaceuticals 2234608*
- Use of aminopeptidase inhibitors or azaindole compounds for preventing or treating cancerous metastases from epithelial origin
Centre National de la Recherche Scientifique 2234610*
- Compsn for treating sterile inflammation
Oy Neurofood 2234611*
- Compsn for stimulating natural killer cell activity
NV Nutricia 2234612*
- P-menthawe-3-carboxylic acid esters to treat airways diseases
Wei, Edward 2234613*
- Pharmaceutical compsn
AOP Orphan Pharmaceuticals 2234614*
- 4-imidazolidionones as KV1.5 potassium channel inhibitors
Wyeth LLC 2234615*
- N-aryl-N-piperidin-4-yl-propionamiode derivatives and their use as monoamine neurotransmitter reuptake inhibitors
NeuroSearch 2234616*
- Dosing regimen associated with long-acting injectable paliperidone esters
Janssen Pharmaceutica 2234617*
- Benzopyrans and analogues as RHO kinase inhibitors
The Scripps Research Institute 2234618*
- Methods and compsns for treating intervertebral disc herniations
Medtronic; Warsaw Orthopaedic 2234619*
- Compsn and methods used during anti-HIV treatment
Université de la Méditerranée 2234620*
- Compsns and methods for treating diseases of the nail
Dow Pharmaceutical Sciences 2234621*
- Methods for enhancing muscle performance and tone
The Salk Institute for Biological Studies 2234622*
- Antiviral compounds
Epiphany Biosciences 2234623*
- Novel vaccines against multiple subtypes of Dengue virus
VGX Pharmaceuticals 2234624*